BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18343204)

  • 1. DNA repair gets physical: mapping an XPA-binding site on ERCC1.
    Croteau DL; Peng Y; Van Houten B
    DNA Repair (Amst); 2008 May; 7(5):819-26. PubMed ID: 18343204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The XPA-binding domain of ERCC1 is required for nucleotide excision repair but not other DNA repair pathways.
    Orelli B; McClendon TB; Tsodikov OV; Ellenberger T; Niedernhofer LJ; Schärer OD
    J Biol Chem; 2010 Feb; 285(6):3705-3712. PubMed ID: 19940136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational determinants for the recruitment of ERCC1 by XPA in the nucleotide excision repair (NER) Pathway: structure and dynamics of the XPA binding motif.
    Fadda E
    Biophys J; 2013 Jun; 104(11):2503-11. PubMed ID: 23746523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional and physical interactions between ERCC1 and MSH2 complexes for resistance to cis-diamminedichloroplatinum(II) in mammalian cells.
    Lan L; Hayashi T; Rabeya RM; Nakajima S; Kanno Si; Takao M; Matsunaga T; Yoshino M; Ichikawa M; Riele Ht; Tsuchiya S; Tanaka K; Yasui A
    DNA Repair (Amst); 2004 Feb; 3(2):135-43. PubMed ID: 14706347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small Molecule Antagonists of the DNA Repair ERCC1/XPA Protein-Protein Interaction.
    Obermann R; Yemane B; Jarvis C; Franco FM; Kyriukha Y; Nolan W; Gohara B; Krezel AM; Wildman SA; Janetka JW
    ChemMedChem; 2024 Apr; 19(8):e202300648. PubMed ID: 38300970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF beta promotes repair of bulky DNA damage through increased ERCC1/XPF and ERCC1/XPA interaction.
    Zheng H; Jarvis IWH; Bottai M; Dreij K; Stenius U
    Carcinogenesis; 2019 Jun; 40(4):580-591. PubMed ID: 30418489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for the recruitment of ERCC1-XPF to nucleotide excision repair complexes by XPA.
    Tsodikov OV; Ivanov D; Orelli B; Staresincic L; Shoshani I; Oberman R; Schärer OD; Wagner G; Ellenberger T
    EMBO J; 2007 Nov; 26(22):4768-76. PubMed ID: 17948053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy.
    Gentile F; Tuszynski JA; Barakat KH
    J Mol Graph Model; 2016 Apr; 65():71-82. PubMed ID: 26939044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERCC1-XPF targeting to psoralen-DNA crosslinks depends on XPA and FANCD2.
    Sabatella M; Pines A; Slyskova J; Vermeulen W; Lans H
    Cell Mol Life Sci; 2020 May; 77(10):2005-2016. PubMed ID: 31392348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential binding of DNA repair proteins RPA and ERCC1 to XPA in vitro.
    Saijo M; Kuraoka I; Masutani C; Hanaoka F; Tanaka K
    Nucleic Acids Res; 1996 Dec; 24(23):4719-24. PubMed ID: 8972858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of nucleotide excision repair by anti-XPA monoclonal antibodies which interfere with binding to RPA, ERCC1, and TFIIH.
    Saijo M; Matsuda T; Kuraoka I; Tanaka K
    Biochem Biophys Res Commun; 2004 Sep; 321(4):815-22. PubMed ID: 15358100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of damage-specific DNA binding of XPA by interaction with the ERCC1 DNA repair protein.
    Nagai A; Saijo M; Kuraoka I; Matsuda T; Kodo N; Nakatsu Y; Mimaki T; Mino M; Biggerstaff M; Wood RD
    Biochem Biophys Res Commun; 1995 Jun; 211(3):960-6. PubMed ID: 7598728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of DNA repair gene expression in human cancer cell lines.
    McGurk CJ; Cummings M; Köberle B; Hartley JA; Oliver RT; Masters JR
    J Cell Biochem; 2006 Apr; 97(5):1121-36. PubMed ID: 16315315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in XPA that prevent association with ERCC1 are defective in nucleotide excision repair.
    Li L; Peterson CA; Lu X; Legerski RJ
    Mol Cell Biol; 1995 Apr; 15(4):1993-8. PubMed ID: 7891694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERCC1, XPF and XPA-locoregional differences and prognostic value of DNA repair protein expression in patients with head and neck squamous cell carcinoma.
    Prochnow S; Wilczak W; Bosch V; Clauditz TS; Muenscher A
    Clin Oral Investig; 2019 Aug; 23(8):3319-3329. PubMed ID: 30498981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle checkpoint abrogator UCN-01 inhibits DNA repair: association with attenuation of the interaction of XPA and ERCC1 nucleotide excision repair proteins.
    Jiang H; Yang LY
    Cancer Res; 1999 Sep; 59(18):4529-34. PubMed ID: 10493501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours.
    Cierna Z; Miskovska V; Roska J; Jurkovicova D; Pulzova LB; Sestakova Z; Hurbanova L; Machalekova K; Chovanec M; Rejlekova K; Svetlovska D; Kalavska K; Kajo K; Babal P; Mardiak J; Ward TA; Mego M; Chovanec M
    BMC Cancer; 2020 Jan; 20(1):17. PubMed ID: 31906898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A disease-associated XPA allele interferes with TFIIH binding and primarily affects transcription-coupled nucleotide excision repair.
    van den Heuvel D; Kim M; Wondergem AP; van der Meer PJ; Witkamp M; Lambregtse F; Kim HS; Kan F; Apelt K; Kragten A; González-Prieto R; Vertegaal ACO; Yeo JE; Kim BG; van Doorn R; Schärer OD; Luijsterburg MS
    Proc Natl Acad Sci U S A; 2023 Mar; 120(11):e2208860120. PubMed ID: 36893274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Domains in the XPA protein important in its role as a processivity factor.
    Bartels CL; Lambert MW
    Biochem Biophys Res Commun; 2007 Apr; 356(1):219-25. PubMed ID: 17349973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin A inhibits nucleotide excision repair via downregulation of the xeroderma pigmentosum group A and G proteins, which is mediated by calcineurin inhibition.
    Kuschal C; Thoms KM; Boeckmann L; Laspe P; Apel A; Schön MP; Emmert S
    Exp Dermatol; 2011 Oct; 20(10):795-9. PubMed ID: 21707758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.